Steatohepatitis
Steatohepatitis
Explore linked clinical trials. Standard reference: MESH:M053357222 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Biomarkers of Steatohepatitis in Type 2 Diabetes Patients | Digestive System Diseases, Nutritional and Metabolic Diseases, Steatohepatitis, diabetes mellitus, endocrine system disorder, fatty liver disease, glucose metabolism disease, liver disorder, metabolic disease | Active, not recruiting | Not stated | 2026-10-07 | NCT07098520 | |
| Diagnosis and Quantification of Hepatic Steatosis Using Near-infrared Spectroscopy | Digestive System Diseases, Steatohepatitis, fatty liver disease, liver disorder | Not yet recruiting | Not applicable | 2026-09-23 | NCT07254533 | |
| Fructose is a Metabolic and Inflammatory Pathogenic Factor in Metabolic Dysfunction-associated Steatohepatitis (MASH) | Digestive System Diseases, Inflammation, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Steatohepatitis, fatty liver disease, liver disorder | Recruiting | Not applicable | 2026-07-31 | NCT07013916 | |
| Impact of Steatotic Liver Disease Associated With Metabolic Dysfunction (MASLD) on Frailty, Cognition, and Quality of Life. A Gender-sensitive Approach Towards a Comprehensive and Equitable Perspective. | Digestive System Diseases, Steatohepatitis, fatty liver disease, liver disorder | Recruiting | Not stated | 2026-06-17 | NCT07652892 | |
| Interventional AI-Human Collaboration for Steatotic Liver Disease Screening | Digestive System Diseases, Fibrosis, Fibrosis, Liver, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Steatohepatitis, cirrhosis of liver, fatty liver disease, liver disorder | Enrolling by invitation | Not applicable | 2026-05-29 | NCT07613827 | |
| Improving Diagnostic Safety Through STeatosis Identification, Risk Stratification, and Referral in the ED | Digestive System Diseases, Steatohepatitis, fatty liver disease, liver disorder, metabolic dysfunction-associated steatotic liver disease | Enrolling by invitation | Not applicable | 2026-05-29 | NCT06944353 | |
| Preoperative Ketogenic Diet for Reduction of Hepatic Steatosis | Digestive System Diseases, Steatohepatitis, fatty liver disease, liver disorder, metabolic dysfunction-associated steatotic liver disease | Recruiting | Not applicable | 2026-05-19 | NCT05884723 | |
| Effect of an Early Time Restricted Eating Mediterranean Diet Compared to Naltrexone/Bupropion on Liver Fibrosis in People With Cardiometabolic Risk Factors in a Hospital Outpatient Clinic (MEDFAST-study) | Body Weight, Digestive System Diseases, Dyslipidemias, Fibrosis, Fibrosis, Liver, Lipid Metabolism Disorders, Nutritional and Metabolic Diseases, Overweight, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Steatohepatitis, cardiovascular disorder, cirrhosis of liver, diabetes mellitus, endocrine system disorder, fatty liver disease, glucose metabolism disease, hypertensive disorder, liver disorder, metabolic disease, metabolic dysfunction-associated steatotic liver disease, nutritional disorder, obesity disorder, overnutrition, type 2 diabetes mellitus, vascular disorder | Enrolling by invitation | Phase 4 | 2026-04-21 | NCT06845345 | |
| Impact of a Probiotic Supplementation With Lifestyle Modification on Liver Steatosis, Fibrosis, and Metabolic Health in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) | Digestive System Diseases, Fibrosis, Insulin Resistance, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Steatohepatitis, cirrhosis of liver, fatty liver disease, glucose metabolism disease, hyperinsulinism, liver disorder, metabolic disease | Recruiting | Not applicable | 2026-04-06 | NCT07400367 | |
| Prevalence and Risk Factors of Metabolic-Associated Hepatic Steatosis in Individuals Living With Type 1 Diabetes | Digestive System Diseases, Fibrosis, Fibrosis, Liver, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Steatohepatitis, autoimmune disease, cirrhosis of liver, diabetes mellitus, endocrine system disorder, fatty liver disease, glucose metabolism disease, immune system disorder, liver disorder, metabolic disease, type 1 diabetes mellitus | Not yet recruiting | Not stated | 2026-03-23 | NCT07475962 | |
| Expanded Studies on the SCAPIS Stockholm Reexamination Cohort | Aneurysm, Arterial Occlusive Diseases, Chronic Disease, Digestive System Diseases, Disease Attributes, Dyslipidemias, Inflammation, Lipid Metabolism Disorders, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Steatohepatitis, aortic aneurysm, aortic disorder, aortic valve disorder, arteriosclerosis disorder, cardiovascular disorder, chronic obstructive pulmonary disease, coronary artery disorder, fatty liver disease, heart disorder, heart failure, heart valve disorder, liver disorder, lung disorder, metabolic disease, myocardial ischemia, obstructive lung disease, respiratory system disorder, vascular disorder | Recruiting | Not stated | 2026-03-17 | NCT07476703 | |
| Endoscopic Ultrasound-guided Large Diameter Lumen-apposing Metal Stent Gastro-gastrostomy for Bypass Reversal in Patients With Roux-en-y Gastric Bypass | Digestive System Diseases, Nutritional and Metabolic Diseases, Steatohepatitis, digestive system disorder, fatty liver disease, glucose metabolism disease, hypoglycemia, liver disorder, metabolic disease, pyloric stenosis, stomach disorder | Recruiting | Not applicable | 2025-10-08 | NCT05640947 | |
| China Health Big Data | Body Weight, Bone Diseases, Metabolic, Digestive System Diseases, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Steatohepatitis, bone disorder, fatty liver disease, liver disorder, metabolic disease, musculoskeletal system disorder, nutritional disorder, obesity disorder, osteoporosis, overnutrition | Recruiting | Not stated | 2025-08-17 | NCT03699228 | |
| Evaluation of a New Ultrasound System for the Non-invasive Assessment of Liver Steatosis in MASLD/MASH Patients | Digestive System Diseases, Fibrosis, Insulin Resistance, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Steatohepatitis, fatty liver disease, glucose metabolism disease, hyperinsulinism, liver disorder, metabolic disease, metabolic dysfunction-associated steatotic liver disease, metabolic syndrome X | Recruiting | Not applicable | 2025-08-15 | NCT06661655 | |
| Evaluation of Non-Invasive Tests for Metabolic Liver Disease | Digestive System Diseases, Fibrosis, Fibrosis, Liver, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Steatohepatitis, cirrhosis of liver, fatty liver disease, hepatitis, liver disorder, metabolic dysfunction-associated steatohepatitis | Recruiting | Not stated | 2025-08-14 | NCT07122700 | |
| CRISPR-Edited HLA Donor Liver Transplant to Reduce Rejection | Digestive System Diseases, Digestive System Neoplasms, Fibrosis, Hepatic Insufficiency, Liver Neoplasms, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Steatohepatitis, cirrhosis of liver, fatty liver disease, liver cancer, liver disorder, liver failure, neoplasm | Recruiting | Phase 1 / Phase 2 | 2025-07-08 | NCT07053488 | |
| LITMUS Imaging Study | Digestive System Diseases, Fibrosis, Fibrosis, Liver, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Steatohepatitis, cirrhosis of liver, disease, fatty liver disease, liver disorder, metabolic dysfunction-associated steatohepatitis, metabolic dysfunction-associated steatotic liver disease | Active, not recruiting | Not stated | 2025-04-16 | NCT05479721 | |
| Ketogenic Diet in MASLD-related cACLD | Digestive System Diseases, Fibrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Steatohepatitis, cirrhosis of liver, fatty liver disease, liver disorder, metabolic dysfunction-associated steatohepatitis, metabolic dysfunction-associated steatotic liver disease | Not yet recruiting | Not applicable | 2024-08-05 | NCT06537466 | |
| Global Research Initiative for Patients Screening on MASH | Body Weight, Digestive System Diseases, Fibrosis, Fibrosis, Liver, Insulin Resistance, Nutritional and Metabolic Diseases, Overweight, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Steatohepatitis, cardiovascular disorder, cirrhosis of liver, diabetes mellitus, endocrine system disorder, fatty liver disease, glucose metabolism disease, hyperinsulinism, hypertensive disorder, liver disorder, metabolic disease, metabolic dysfunction-associated steatohepatitis, metabolic dysfunction-associated steatotic liver disease, nutritional disorder, obesity disorder, overnutrition, type 2 diabetes mellitus, vascular disorder | Recruiting | Not stated | 2024-08-01 | NCT05651724 | |
| Acceptability and Feasibility of a New Approach to Engage Patients With Steatotic Liver Disease in Physical Activity | Digestive System Diseases, Steatohepatitis, fatty liver disease, liver disorder, metabolic dysfunction-associated steatohepatitis, metabolic dysfunction-associated steatotic liver disease | Not yet recruiting | Not applicable | 2024-06-06 | NCT06446908 | |
| The European NAFLD Registry | Body Weight, Digestive System Diseases, Digestive System Neoplasms, Dyslipidemias, Fibrosis, Fibrosis, Liver, Lipid Metabolism Disorders, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Nutritional and Metabolic Diseases, Overweight, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Steatohepatitis, adenocarcinoma, carcinoma, cardiovascular disorder, cirrhosis of liver, diabetes mellitus, endocrine system disorder, epithelial neoplasm, fatty liver disease, glucose metabolism disease, hepatocellular carcinoma, hypertensive disorder, liver disorder, metabolic disease, metabolic dysfunction-associated steatohepatitis, metabolic dysfunction-associated steatotic liver disease, neoplasm, nutritional disorder, obesity disorder, overnutrition, type 2 diabetes mellitus, vascular disorder | Recruiting | Not stated | 2023-01-06 | NCT04442334 | |
| Randomized Clinical Trial; Medical vs Bariatric Surgery for Adolescents (13-16 y) With Severe Obesity | Body Weight, Digestive System Diseases, Inflammation, Nutritional and Metabolic Diseases, Overweight, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Steatohepatitis, cardiovascular disorder, diabetes mellitus, endocrine system disorder, fatty liver disease, glucose metabolism disease, hypertensive disorder, liver disorder, metabolic disease, nutritional disorder, obesity disorder, overnutrition, vascular disorder | Active, not recruiting | Not applicable | 2022-03-25 | NCT02378259 |